[
    [
        {
            "time": "2021-06-08",
            "original_text": "长春高新“拿下”新冠疫苗喷剂 将向思安信累计付款约8.4亿",
            "features": {
                "keywords": [
                    "长春高新",
                    "新冠疫苗",
                    "喷剂",
                    "思安信",
                    "8.4亿"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "长春高新“拿下”新冠疫苗喷剂 将向思安信累计付款约8.4亿",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-08",
            "original_text": "险资一个月调研235家A股上市公司： 最青睐生物科技、医疗保健行业",
            "features": {
                "keywords": [
                    "险资",
                    "调研",
                    "生物科技",
                    "医疗保健"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "医疗保健"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "险资一个月调研235家A股上市公司： 最青睐生物科技、医疗保健行业",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-08",
            "original_text": "速读社丨FDA批准阿尔茨海默病药Aduhelm 恒瑞、阿斯利康等多款重磅药物新适应症即将获批",
            "features": {
                "keywords": [
                    "FDA",
                    "阿尔茨海默病",
                    "Aduhelm",
                    "恒瑞",
                    "阿斯利康"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "速读社丨FDA批准阿尔茨海默病药Aduhelm 恒瑞、阿斯利康等多款重磅药物新适应症即将获批",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-08",
            "original_text": "长春高新：根据相关行业数据，国际市场中成人生长激素约占总份额的60%-70%左右",
            "features": {
                "keywords": [
                    "长春高新",
                    "成人生长激素",
                    "国际市场",
                    "份额"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "长春高新：根据相关行业数据，国际市场中成人生长激素约占总份额的60%-70%左右",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-08",
            "original_text": "A股资金流向（6月8日）：白酒股巨量杀跌，资金大幅出逃",
            "features": {
                "keywords": [
                    "A股",
                    "资金流向",
                    "白酒股",
                    "杀跌",
                    "出逃"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股资金流向（6月8日）：白酒股巨量杀跌，资金大幅出逃",
                "Correlation": 3,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06-08",
            "original_text": "长春高新：公司暂无鼻喷新冠疫苗相关产品上市",
            "features": {
                "keywords": [
                    "长春高新",
                    "鼻喷新冠疫苗",
                    "产品上市"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "长春高新：公司暂无鼻喷新冠疫苗相关产品上市",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-08",
            "original_text": "长春高新：公司目前生产经营一切正常",
            "features": {
                "keywords": [
                    "长春高新",
                    "生产经营",
                    "正常"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "长春高新：公司目前生产经营一切正常",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 4,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-08",
            "original_text": "东莞证券维持长春高新推荐评级，事件点评：鼻喷新冠疫苗顺利推进，业务管线更完善",
            "features": {
                "keywords": [
                    "东莞证券",
                    "长春高新",
                    "鼻喷新冠疫苗",
                    "推荐评级"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "东莞证券维持长春高新推荐评级，事件点评：鼻喷新冠疫苗顺利推进，业务管线更完善",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-08",
            "original_text": "长春高新“入局”新冠疫苗，拟8.4亿元获得思安信独家授权",
            "features": {
                "keywords": [
                    "长春高新",
                    "新冠疫苗",
                    "思安信",
                    "独家授权"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "长春高新“入局”新冠疫苗，拟8.4亿元获得思安信独家授权",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        }
    ]
]